EcoDrugPlus

Neurotensin Receptor 1

Ensembl ID : ENSSTUG00000034718
Gene Symbol: NTSR1
1 Cross references
197 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSSTUG00000024717
Gene Symbol: NTRK2
3 Cross references
203 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSSTUG00000038382
Gene Symbol: NTRK2
3 Cross references
202 Possible Orthologues:

Neurotrophic Tyrosine Kinase, Receptor, Type 2b

Ensembl ID : ENSSTUG00000031090
Gene Symbol: NTRK2B
1 Cross references
203 Possible Orthologues:

Nicastrin

Ensembl ID : ENSSTUG00000015222
Gene Symbol: NCSTN
3 Cross references
197 Possible Orthologues:

Nicastrin

Ensembl ID : ENSSTUG00000003311
Gene Symbol: NCSTN
3 Cross references
197 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSSTUG00000039504
Gene Symbol: NAMPT
3 Cross references
217 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSSTUG00000041241
Gene Symbol: NAMPT
3 Cross references
154 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSSTUG00000024831
Gene Symbol: NAMPT
3 Cross references
221 Possible Orthologues:

Nischarin

Ensembl ID : ENSSTUG00000045443
Gene Symbol: NISCH
3 Cross references
207 Possible Orthologues:

Nitric Oxide Synthase 2

Ensembl ID : ENSSTUG00000038401
Gene Symbol: NOS2
3 Cross references
160 Possible Orthologues:

Nitric Oxide Synthase 2

Ensembl ID : ENSSTUG00000011802
Gene Symbol: NOS2
1 Cross references
159 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).